Puma Biotechnology
PBYI
PBYI
178 hedge funds and large institutions have $2.42B invested in Puma Biotechnology in 2018 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 83 increasing their positions, 51 reducing their positions, and 47 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
178
Holders Change
-25
Holders Change %
-12.32%
% of All Funds
4.09%
Holding in Top 10
4
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-33.33%
% of All Funds
0.09%
New
25
Increased
83
Reduced
51
Closed
47
Calls
$29.6M
Puts
$38.1M
Net Calls
-$8.5M
Net Calls Change
-$3.18M
Top Buyers
1 |
Point72 Asset Management
Stamford,
Connecticut
|
$87.2M |
2 |
ACA
Avoro Capital Advisors
New York
|
$56.2M |
3 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
$34M |
4 |
Jennison Associates
New York
|
$33M |
5 |
O
OrbiMed
New York
|
$180M |